These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 1325432

  • 21. Regulation of the expression of the regulatory subunit of cAMP-dependent protein kinase II beta in Friend erythroleukemic cells. Evidence for posttranscriptional control and a central role for the C subunit.
    Gross RE, Lu XY, Rubin CS.
    J Biol Chem; 1990 May 15; 265(14):8152-8. PubMed ID: 1692323
    [Abstract] [Full Text] [Related]

  • 22. Reversal of resistance to adriamycin by 8-chloro-cyclic AMP in adriamycin-resistant HL-60 leukemia cells is associated with reduction of type I cyclic AMP-dependent protein kinase and cyclic AMP response element-binding protein DNA-binding activities.
    Rohlff C, Safa B, Rahman A, Cho-Chung YS, Klecker RW, Glazer RI.
    Mol Pharmacol; 1993 Mar 15; 43(3):372-9. PubMed ID: 8383802
    [Abstract] [Full Text] [Related]

  • 23. Interactions between the epidermal growth factor receptor and type I protein kinase A: biological significance and therapeutic implications.
    Ciardiello F, Tortora G.
    Clin Cancer Res; 1998 Apr 15; 4(4):821-8. PubMed ID: 9563874
    [Abstract] [Full Text] [Related]

  • 24. Increased activity of type I regulatory subunit of cyclic adenosine 3',5'-monophosphate-dependent protein kinase in estrogen-induced pituitary tumors.
    Piroli G, Pignataro O, De Nicola AF.
    J Natl Cancer Inst; 1992 Oct 21; 84(20):1565-71. PubMed ID: 1328659
    [Abstract] [Full Text] [Related]

  • 25. The cAMP analog 8-Cl-cAMP inhibits growth and induces differentiation and apoptosis in retinoblastoma cells.
    Fassina G, Aluigi MG, Gentleman S, Wong P, Cai T, Albini A, Noonan DM.
    Int J Cancer; 1997 Sep 17; 72(6):1088-94. PubMed ID: 9378544
    [Abstract] [Full Text] [Related]

  • 26. Unhydrolyzable analogues of adenosine 3':5'-monophosphate demonstrating growth inhibition and differentiation in human cancer cells.
    Yokozaki H, Tortora G, Pepe S, Maronde E, Genieser HG, Jastorff B, Cho-Chung YS.
    Cancer Res; 1992 May 01; 52(9):2504-8. PubMed ID: 1314695
    [Abstract] [Full Text] [Related]

  • 27. [Effects of site-selective 8-Cl-cAMP on the growth regulation of human lung giant cell cancer].
    Zhang J, Fang W, Wu B.
    Zhonghua Zhong Liu Za Zhi; 1995 Mar 01; 17(2):108-11. PubMed ID: 7656798
    [Abstract] [Full Text] [Related]

  • 28. Experimental gene therapy of human colon cancer.
    Bold RJ, Warren RE, Ishizuka J, Cho-Chung YS, Townsend CM, Thompson JC.
    Surgery; 1994 Aug 01; 116(2):189-95; discussion 195-6. PubMed ID: 8047985
    [Abstract] [Full Text] [Related]

  • 29. 8-chloroadenosine 3',5'-monophosphate (8-Cl-cAMP) selectively eliminates protein kinase A type I to induce growth inhibition in c-ras-transformed fibroblasts.
    Noguchi K, Murata T, Cho-Chung YS.
    Eur J Cancer; 1998 Jul 01; 34(8):1260-7. PubMed ID: 9849489
    [Abstract] [Full Text] [Related]

  • 30. Antitumor effects of butyrolactone I, a selective cdc2 kinase inhibitor, on human lung cancer cell lines.
    Nishio K, Ishida T, Arioka H, Kurokawa H, Fukuoka K, Nomoto T, Fukumoto H, Yokote H, Saijo N.
    Anticancer Res; 1996 Jul 01; 16(6B):3387-95. PubMed ID: 9042196
    [Abstract] [Full Text] [Related]

  • 31. Cooperative effect of 8-Cl-cAMP and rhGM-CSF on the differentiation of HL-60 human leukemia cells.
    Tortora G, Pepe S, Yokozaki H, Meissner S, Cho-Chung YS.
    Biochem Biophys Res Commun; 1991 Jun 28; 177(3):1133-40. PubMed ID: 2059204
    [Abstract] [Full Text] [Related]

  • 32. The mechanism of the difference in cellular uptake of platinum derivatives in non-small cell lung cancer cell line (PC-14) and its cisplatin-resistant subline (PC-14/CDDP).
    Ohmori T, Morikage T, Sugimoto Y, Fujiwara Y, Kasahara K, Nishio K, Ohta S, Sasaki Y, Takahashi T, Saijo N.
    Jpn J Cancer Res; 1993 Jan 28; 84(1):83-92. PubMed ID: 8383649
    [Abstract] [Full Text] [Related]

  • 33. Synergistic inhibition of growth of breast and colon human cancer cell lines by site-selective cyclic AMP analogues.
    Tagliaferri P, Katsaros D, Clair T, Ally S, Tortora G, Neckers L, Rubalcava B, Parandoosh Z, Chang YA, Revankar GR.
    Cancer Res; 1988 Mar 15; 48(6):1642-50. PubMed ID: 2830966
    [Abstract] [Full Text] [Related]

  • 34. Site-selective 8-chloroadenosine 3',5'-cyclic monophosphate inhibits transformation and transforming growth factor alpha production in Ki-ras-transformed rat fibroblasts.
    Tortora G, Ciardiello F, Ally S, Clair T, Salomon DS, Cho-Chung YS.
    FEBS Lett; 1989 Jan 02; 242(2):363-7. PubMed ID: 2536620
    [Abstract] [Full Text] [Related]

  • 35. Growth inhibition by cholera toxin of human lung carcinoma cell lines: correlation with GM1 ganglioside expression.
    Kaur G, Viallet J, Laborda J, Blair O, Gazdar AF, Minna JD, Sausville EA.
    Cancer Res; 1992 Jun 15; 52(12):3340-6. PubMed ID: 1375868
    [Abstract] [Full Text] [Related]

  • 36. Cyclic AMP-dependent protein kinase (cAK) in human B cells: co-localization of type I cAK (RI alpha 2 C2) with the antigen receptor during anti-immunoglobulin-induced B cell activation.
    Levy FO, Rasmussen AM, Taskén K, Skålhegg BS, Huitfeldt HS, Funderud S, Smeland EB, Hansson V.
    Eur J Immunol; 1996 Jun 15; 26(6):1290-6. PubMed ID: 8647207
    [Abstract] [Full Text] [Related]

  • 37. Constitutive levels of cAMP-dependent protein kinase activity determine sensitivity of human multidrug-resistant leukaemic cell lines to growth inhibition and apoptosis by forskolin and tumour necrosis factor alpha.
    Yin Y, Allen PD, Jia L, MacEy MG, Kelsey SM, Newland AC.
    Br J Haematol; 2000 Mar 15; 108(3):565-73. PubMed ID: 10759715
    [Abstract] [Full Text] [Related]

  • 38. Growth-regulatory effect of gastrin on human colon cancer cell lines is determined by protein kinase a isoform content.
    Bold RJ, Alpard S, Ishizuka J, Townsend CM, Thompson JC.
    Regul Pept; 1994 Aug 31; 53(1):61-70. PubMed ID: 7800859
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Functional changes in the regulatory subunit of the type II cyclic adenosine 3':5'-monophosphate-dependent protein kinase isozyme during normal and neoplastic lung development.
    Butley MS, Beer DG, Malkinson AM.
    Cancer Res; 1984 Jun 31; 44(6):2689-97. PubMed ID: 6327022
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.